00013 HUTCHMED

Watchlist

27.750
+0.550+2.02%

Trading Dec 4 10:03 CST

24.19BMarket Cap-73803P/E (TTM)

About HUTCHMED Company

Hutchison Pharmaceutical is an innovative biomedical company in the commercialization stage, aiming to become a global leader in the discovery, development and commercialization of targeted therapies and immunotherapy treatments for cancer and immune diseases. We are one of the first innovative pharmaceutical R&D companies in China to focus on the global market. Over the past 20 years, we have built a fully integrated R&D innovation platform with world-class discovery and development capabilities. As of 2020, we currently have a research and development team composed of about 600 professionals and 10 clinical-stage innovative anti-cancer drugs that are undergoing clinical research worldwide. We have also established a deep and profitable commercial platform in the Chinese market to manufacture, market and distribute prescription drugs and consumer health products in China, as well as our two innovative oncology drugs that have already been marketed in China — iutac (fruquintinib capsules) and suteta (surufatinib capsules). We are also expanding our commercialization footprint further into the US and Europe. Hutchison Pharmaceutical is listed on the Nasdaq Global Select Market and the London Alternative Investment Market (NASDAQ/London Stock Exchange: HCM).

Company Profile

Symbol00013

Company NameHutchmed (China) co.,Ltd.

ISINKYG4672N1198

Listing DateJun 30, 2021

Issue Price40.10

Shares Offered104.00M share(s)

FoundedDec 18, 2000

Registered AddressCayman Islands

Chairmanlede ai

Secretaryxide shi

Audit InstitutionPricewaterhouseCoopers

Company CategoryOther

Registered OfficeP.O. Box 309, Ugland House Grand Cayman, KY1-1104 Cayman Islands

Head Office and Principal Place of Business48th Floor, Cheung Kong Group Centre, 2 Queen's Road Central, Hong Kong

Fiscal Year Ends12-31

Employees1970

MarketHong Kong motherboard

Phone(852)21281188;(852)21218200

Fax(852)21281778;(852)21218281

Emailinfo@hutch-med.com;ediths@ckh.com.hk

Websitehttps://www.hutch-med.com

BusinessHUTCHMED China Ltd, formerly Hutchison China Meditech Ltd, is an investment holding company principally engaged in the manufacturing and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Oncology and Immunology segment is engaged in discovering, developing, and commercializing targeted therapies and immunotherapies for the treatment of cancer and immunological diseases, including research and development activities covering drug discovery, development, manufacturing and regulatory functions as well as administrative activities to support research and development operations, also covering sales, marketing, manufacturing and distribution of drug developed from research and development activities. The Other Ventures segment is involved in other commercial businesses including the sales, marketing, manufacturing and distribution of other prescription drugs and over-the-counter pharmaceuticals as well as consumer health products.